0001437749-23-018281.txt : 20230623
0001437749-23-018281.hdr.sgml : 20230623
20230623164613
ACCESSION NUMBER: 0001437749-23-018281
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230621
FILED AS OF DATE: 20230623
DATE AS OF CHANGE: 20230623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIRITSY CHRISTOPHER P
CENTRAL INDEX KEY: 0001261156
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37471
FILM NUMBER: 231038380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PIERIS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001583648
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300784346
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-246-8998
MAIL ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
FORMER COMPANY:
FORMER CONFORMED NAME: Marika Inc.
DATE OF NAME CHANGE: 20130805
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-06-21
0001583648
PIERIS PHARMACEUTICALS, INC.
PIRS
0001261156
KIRITSY CHRISTOPHER P
C/O PIERIS PHARMACEUTICALS, INC.
225 FRANKLIN STREET, 26TH FLOOR
BOSTON
MA
02110
1
0
Stock Option (right to buy)
0.26
2023-06-21
4
A
0
40000
0
A
2033-06-21
Common Stock
40000
40000
D
The stock option will vest as to 100% of the underlying shares on the date of the Company's 2024 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date.
/s/ Ahmed Mousa, Attorney-in-Fact
2023-06-23